Vanberra Signal

ConcR

Curated by Signal

Provides AI-based decision support tools and software for cancer diagnosis and drug designing

Overview

Concr provides AI-based software solutions and tools to healthcare professionals for decision making and predictive analysis. The tools provided by the company assist in the process of diagnosis and treatment of cancer. The tool is also used for drug designing for cancer therapy treatments. The software has the ability to model and detect tumor progression. The predictive analytics software can identify biomarkers from multi-omic data that can be used for clinical trials and for optimizing the therapy plan.

Key facts

Founded
2018

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Digital administrative workflow management tool for healthcare professionals

    Health TechnologyLondon, United Kingdom
  • Provider of customer relationship management solutions for personal trainers

    Health TechnologyUnited Kingdom
  • Provider of AI-based application offering nutrition guidance to users

    Health TechnologyBromley, United Kingdom

About ConcR

What does ConcR do?

Concr provides AI-based software solutions and tools to healthcare professionals for decision making and predictive analysis.

Where is ConcR headquartered?

ConcR is headquartered in London, United Kingdom.

When was ConcR founded?

ConcR was founded in 2018.

Which sector is ConcR in?

ConcR operates in Health Technology.

Who are ConcR's competitors?

Companies similar to ConcR include GProta, PT Buddy, and Nyootrition.